Sanofi follows Shell with €2bn triple tranche bond
Sanofi, the French pharmaceuticals company, priced a €2bn three tranche bond on Monday amid heavy supply in the European corporate bond market.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts